The inhibition of PAK4 suppressed tumor growth by stimulating the infiltration of cytotoxic T cells and by sensitizing the tumor response to immune checkpoint inhibitors and to CAR-T immunotherapy [13,14,17]. Here, PAK4 is linked to neoplasm.